Initiation Of Enrollment In Pivotal Phase III Clinical Study Of Oral Laquinimod For Relapsing-Remitting Multiple Sclerosis
Jerusalem, Israel and Lund, Sweden,
Teva Pharmaceutical Industries Ltd. ... more »
|
|||
|
Multiple Sclerosis Info
If you want this blog to continue, than make it financialy viable for Bonnie to continue it. She puts in 2-3 hours a day into this blog, and spends money on it for it's upkeep.
Search
This Month
|
Sunday, December 30
by
All About MS
on Sun 30 Dec 2007 09:18 AM CST
Initiation Of Enrollment In Pivotal Phase III Clinical Study Of Oral Laquinimod For Relapsing-Remitting Multiple Sclerosis
Teva Pharmaceutical Industries Ltd. ... more »
by
All About MS
on Sun 30 Dec 2007 09:13 AM CST
Can a vitamin alleviate chronic, progressive multiple sclerosis? |
||